definiens: meansany and all cell - based technique for the detection, diagnosis or prognostic testing related to any neurodegenerativedisorder, including without limitation, Alzheimer ’s Disease . The Transferred Assets specifically include, withoutlimitation : 1.1 all of the intellectual property owned by MDx as of the Closing Date ( the ), including : ( a ) any and all patents and patent applications ( respectively issued or filed throughout the world ), ownedby MDx as of the Closing Date, as well as any extensions, divisions, continuations and continuation - in - parts thereofand any applications or patents that claim priority from such patents and applications, including, without limitation, any foreign counterparts of such patents, in each case related to the LymPro Technology ; ( b ) the copyrights owned by MDx as of the Closing Date related to the LymPro Technology ; ( c ) all other intellectual property and technology, including, without limitation, know - how, trade secrets, inventions ( whether or not patented ), data, techniques, materials, clinical and pre - clinical protocols, designs, formulas, processes, procedures, methods, source code, software, databases, works of authorship, and all documentation andinformation relating to the design, manufacture, testing, installation, operation, repair, maintenance, support and useof the LymPro Technology ; ( d ) the right to sue and recover damages for past, present and future infringement of any intellectualproperty